What is Disseminated Intravascular Coagulation?

Disseminated intravascular coagulation (DIC) is a condition where the body forms an excess of blood clots throughout the body’s small and large blood vessels, which can disrupt blood flow and lead to multiple organ dysfunction syndrome (MODS). As the body uses up all its clotting factors and platelets to form these clots, it can lead to bleeding, which is often the first sign noticed in a patient with DIC. This condition usually arises as a sudden complication in patients dealing with severe underlying illnesses like severe infections, blood cancers, serious injuries, or complications during pregnancy like placental abruption.

Determining the outcome and mortality rate of DIC is tricky because these patients often have other diseases that can cause similar symptoms, especially if they also have liver failure, either acute or chronic. While these concurrent diseases can make it hard to predict a patient’s survival chances, it has been evidenced that the mortality rates can double in patients with infections or severe injuries if they also have DIC.

What Causes Disseminated Intravascular Coagulation?

Disseminated intravascular coagulation, or DIC, is a condition that can be caused by several different medical conditions. These conditions trigger an overactive response from the body’s immune system or release certain substances that promote blood clotting into the bloodstream. DIC has been found to occur in about 30% to 50% of severe sepsis cases, making it the most common cause. It is generally associated with a kind of sepsis caused by specific bacteria, but it can also occur in sepsis caused by other types of bacteria, and even parasites.

Up to 20% of patients with advanced adenocarcinoma (a type of cancer) or diseases impacting the body’s lymph cells may also develop DIC. Additionally, about 1% to 5% of patients with chronic conditions, such as solid tumors and aortic aneurysms, can be affected.

Obstetrical complications including problems with the placenta, damage to red blood cells and liver enzymes, low platelet count like in HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelet count), and issues with the amniotic fluid can also lead to DIC. Other causes can include trauma, pancreatitis (inflammation of the pancreas), cancer, snake bites, liver disease, organ transplant rejection, and reactions to a blood transfusion. Around 15.5% of DIC cases have also been related to complications after surgery.

Risk Factors and Frequency for Disseminated Intravascular Coagulation

DIC, also known as Disseminated Intravascular Coagulation, is a condition that often appears as a complication of other serious health issues. This means it’s more common in high-risk health settings. It was found that about 1% of hospital admissions in Japan related to DIC, based on a study conducted in 1996. Another study found that it affected 12% of cases of acute lymphoblastic leukemia before beginning chemotherapy. During remission induction, DIC was present in a staggering 78% of cases. Another health condition, HELLP syndrome, was found to be associated with DIC in about 20% of cases, as per a study done in 1993.

  • DIC is often a complication of other high-risk health conditions.
  • It’s more common in situations of serious medical concern.
  • About 1% of hospital admissions in Japan relate to DIC, as per a 1996 study.
  • DIC was found in 12% of acute lymphoblastic leukemia cases before starting chemotherapy, according to a 1992 study.
  • A startling 78% of cases were found to have DIC during remission induction.
  • An association was found between DIC and HELLP syndrome in roughly 20% of cases, based on a 1993 study.

Signs and Symptoms of Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (DIC) is a serious health issue that may be indicated by a patient’s history revealing recent severe infections, trauma, liver failure, complications during pregnancy, or cancer. A past experience with deep vein or arterial blood clots can also hint towards DIC. Be on the lookout for these symptoms:

  • Bleeding from multiple locations such as the gums, surgical wounds, vagina, rectum, or through urinary catheters
  • Signs of renal failure like blood in urine, reduced urine production, or no urine at all (hematuria, oliguria, and anuria)
  • Breathing difficulties and coughing up blood can occur if the lungs are affected (dyspnea and hemoptysis)
  • Changes in mental state, possibly due to blood clots or hemorrhage in the brain
  • Chest pain, potentially due to blockage of a coronary artery

Physical signs of DIC could be visually observed bleeding or clearly apparent bruising in various parts of the body. Skin damage might include bruises (ecchymosis), blood clots (hematomas), yellowing due to liver failure (jaundice), dead tissues (necrosis), and tissue death resulting in blackened skin (gangrene). Other symptoms could involve widespread rashes (purpura), pinpoint, unraised, round red spots under the skin caused by bleeding (petechiae), and bluish discoloration of the skin due to poor circulation (cyanosis). Based on where bleeding or clots are located, the patient might experience sudden respiratory failure or neurologic deficits.

Testing for Disseminated Intravascular Coagulation

Diagnosing Disseminated Intravascular Coagulation (DIC), a serious condition that affects the blood’s ability to clot, requires a combination of different checks and tests. These checks often include various parameters from you and your health history, a physical exam, and laboratory tests.

Lab tests can provide critical clues if DIC is suspected. You might see elevated results for clotting times, namely prothrombin time (PT) and partial thromboplastin time (PTT). There could also be a decrease in the levels of fibrinogen, which plays a significant role in blood clot formation. This happens because the clotting factors in the blood are being used up rapidly in DIC.

In addition to changes in clotting times and fibrinogen levels, the total count of platelets (which help the blood to clot) and the proportion of blood volume that is made up of red blood cells (known as hematocrit level) might also decrease. A peripheral blood smear test is another laboratory test performed where blood is examined under a microscope. In cases of DIC, this test often shows schistocytes, which are damaged, fragmented red blood cells.

Another red flag for DIC includes the presence of by-products from the breakdown of fibrin (a protein that forms a clot’s stable structure) in the blood. Though these by-products, called fibrin split products, are highly “sensitive” (meaning they usually show up in DIC cases), they are not “specific” (meaning they can show up in several other conditions, as well).

In 2007, a specific scoring system was established to check for DIC. It takes the platelet count, fibrin markers like D-dimer, PT, and the fibrinogen level into account. A score over 5 on this system indicates that DIC is highly likely.

Treatment Options for Disseminated Intravascular Coagulation

The treatment for DIC, or Disseminated Intravascular Coagulation, involves tackling the root cause of the condition. This might mean giving antibiotics to treat severe sepsis, considering delivery in case of placental abruption, or thinking about surgery in cases of trauma. These are the main treatments for DIC. Only patients who are bleeding or have a high risk of bleeding, or those needing surgery, should get transfusions of platelets and plasma.

Doctors often use specific platelet count thresholds to decide whether a patient needs a transfusion. If a patient is bleeding severely, they might receive a transfusion if their platelet count drops below 50 x 109 platelets per liter of blood. For patients who aren’t actively bleeding but have a high risk of future bleeding, the threshold is lower, around 10-20 x 109 platelets per liter.

Similarly, doctors might give fresh frozen plasma or cryoprecipitate to replace the clotting factors in the blood. The usual dose is between 15 and 30 milliliters of plasma per kilogram of the patient’s weight. In some cases, a medication called prothrombin complex concentrate might be used. This medication only contains some clotting factors and slightly improves a patient’s ability to stop bleeding.

If a patient has extensive clotting, the physician may also prescribe Heparin to prevent further activation of the clotting process. In cases where a patient with DIC isn’t actively bleeding, a preventative dose of Heparin or Low Molecular Weight Heparin (LMWH) may be given to prevent unnecessary blood clots.

When a doctor is trying to diagnose disseminated intravascular coagulation – a condition that causes blood clots to form in the body’s small blood vessels – they also consider other health conditions that have similar symptoms. Here is a list of these conditions:

  • Dysfibrinogenemia (a rare blood disorder)
  • Hemolytic uremic syndrome (a condition that affects the blood and blood vessels)
  • Heparin-induced thrombocytopenia (a reaction to a medication that decreases platelets)
  • Immune thrombocytopenia (ITP, a disorder that can lead to easy or excessive bruising and bleeding)
  • Thrombotic thrombocytopenic purpura (TTP, a blood condition that causes blood clots to form in small blood vessels around the body)

It’s crucial for the physician to rule out these possible causes and perform the appropriate tests to ensure a precise diagnosis is reached.

Frequently asked questions

Disseminated Intravascular Coagulation (DIC) is a condition where the body forms an excess of blood clots throughout the body's small and large blood vessels, which can disrupt blood flow and lead to multiple organ dysfunction syndrome (MODS).

Disseminated Intravascular Coagulation is often a complication of other high-risk health conditions.

Signs and symptoms of Disseminated Intravascular Coagulation (DIC) include: - Bleeding from multiple locations such as the gums, surgical wounds, vagina, rectum, or through urinary catheters. - Signs of renal failure like blood in urine, reduced urine production, or no urine at all (hematuria, oliguria, and anuria). - Breathing difficulties and coughing up blood can occur if the lungs are affected (dyspnea and hemoptysis). - Changes in mental state, possibly due to blood clots or hemorrhage in the brain. - Chest pain, potentially due to blockage of a coronary artery. Physical signs of DIC could be visually observed bleeding or clearly apparent bruising in various parts of the body. Other symptoms could involve: - Bruises (ecchymosis). - Blood clots (hematomas). - Yellowing due to liver failure (jaundice). - Dead tissues (necrosis). - Tissue death resulting in blackened skin (gangrene). - Widespread rashes (purpura). - Pinpoint, unraised, round red spots under the skin caused by bleeding (petechiae). - Bluish discoloration of the skin due to poor circulation (cyanosis). Based on where bleeding or clots are located, the patient might experience sudden respiratory failure or neurologic deficits.

Disseminated Intravascular Coagulation can be caused by several different medical conditions, including severe sepsis, advanced adenocarcinoma or diseases impacting the body's lymph cells, obstetrical complications, trauma, pancreatitis, cancer, snake bites, liver disease, organ transplant rejection, reactions to a blood transfusion, and complications after surgery.

Dysfibrinogenemia, Hemolytic uremic syndrome, Heparin-induced thrombocytopenia, Immune thrombocytopenia (ITP), Thrombotic thrombocytopenic purpura (TTP)

The types of tests needed for Disseminated Intravascular Coagulation (DIC) include: - Parameters from the patient's health history and physical exam - Laboratory tests, such as: - Prothrombin time (PT) and partial thromboplastin time (PTT) to check clotting times - Fibrinogen levels to assess blood clot formation - Platelet count to evaluate blood clotting ability - Hematocrit level to determine the proportion of red blood cells in the blood - Peripheral blood smear test to examine damaged red blood cells (schistocytes) - Fibrin split products to detect breakdown of fibrin in the blood - Scoring system that considers platelet count, fibrin markers, PT, and fibrinogen level to assess the likelihood of DIC - Additional tests may be ordered based on the patient's specific condition and symptoms.

The treatment for Disseminated Intravascular Coagulation (DIC) involves addressing the underlying cause of the condition. This may include administering antibiotics for severe sepsis, considering delivery in the case of placental abruption, or considering surgery for trauma cases. Platelet and plasma transfusions are only given to patients who are bleeding or at high risk of bleeding, or those who require surgery. Doctors use specific platelet count thresholds to determine if a transfusion is necessary, with a lower threshold for patients at high risk of future bleeding. Additionally, clotting factors in the blood can be replaced with fresh frozen plasma, cryoprecipitate, or prothrombin complex concentrate. In cases of extensive clotting, Heparin may be prescribed to prevent further activation of the clotting process, and a preventative dose of Heparin or Low Molecular Weight Heparin (LMWH) may be given to patients with DIC who are not actively bleeding.

The text does not mention any specific side effects when treating Disseminated Intravascular Coagulation (DIC).

Determining the prognosis for Disseminated Intravascular Coagulation (DIC) can be difficult due to the presence of concurrent diseases. However, it has been observed that the mortality rates can double in patients with infections or severe injuries if they also have DIC. The outcome and mortality rate of DIC can vary depending on the underlying health conditions and complications.

Hematologist

Join our newsletter

Stay up to date with the latest news and promotions!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

We care about your data in our privacy policy.